Keyword: R&D

News

MRC Licenses Hepatitis C Antibody to China

21.03.2017 - UK medical research charity MRC Technology has licensed an antibody to Newsummit Biopharma, a leading Chinese drug developer, in an effort to create a novel therapeutic for...

News

Allergan and Editas Medicine in Eye Disease Pact

20.03.2017 - Allergan has secured exclusive access to Editas Medicine’s genome-editing ocular programs under a strategic research and development agreement. The deal covers early stage, first...

News

Envigo Creates Non-animal Cardiac Tests

17.03.2017 - UK contract research organization Envigo has announced it will develop and internally validate five to seven ion channel in vitro tests for measuring cardiac risk potential. The...

News

BASF Inaugurates Indian Innovation Campus

14.03.2017 - BASF has inaugurated its new Innovation Campus Asia Pacific in Mumbai, India its largest R&D investment in South Asia to date. The €50 million investment is said to “significantly...

News

Lianhetech Enters Europe with Fine Industries Buy

07.03.2017 - Chinese life sciences company Lianhe Chemical Technology (Lianhetech) has gained its first base in Europe after agreeing to buy UK-based chemical manufacturer Fine Industries in a...

News

MEPs Take on EU Drug Pricing

06.03.2017 - At a plenary session last week, the European Parliament (EP) discussed the trend toward rising drug prices in the EU over the past few decades and drafted proposals for dealing...

News

Cancer Research UK and HitGen in Pact

03.03.2017 - Cancer Research UK, its commercial arm Cancer Research Technology (CRT) and Chinese life science company HitGen have entered into a license agreement to develop a novel class of...

News

FDA Accepts Merck-Pfizer Biologics Application

01.03.2017 - In the course of only a week, the US Food and Drug Administration FDA) has accepted the second Biologics License Application (BLA) for priority review. In the latest case, the...